Ligand Pharmaceuticals Incorporated (LGND)

NASDAQ: LGND · Real-Time Price · USD

319.43

-0.99 (-0.31%)

At close: Jul 7, 2026, 4:00 PM EDT

318.00

-1.43 (-0.45%)

After-hours: Jul 7, 2026, 5:06 PM EDT

Ligand Pharmaceuticals Ratios and Metrics

Market cap in millions USD. Fiscal year is January - December.

Millions USD. Fiscal year is Jan - Dec.

Fiscal Year	Current	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Jul '26 Jul 7, 2026	Dec '25 Dec 31, 2025	Dec '24 Dec 31, 2024	Dec '23 Dec 31, 2023	Dec '22 Dec 31, 2022	Dec '21 Dec 31, 2021
Market Cap	6,329	3,739	2,047	1,254	1,132	2,590
Market Cap Growth	186.12%	82.62%	63.27%	10.73%	-56.28%	61.95%
Enterprise Value	5,933	3,457	1,798	1,090	1,008	2,573
Last Close Price	319.43	189.07	107.15	71.42	66.80	154.46
PE Ratio	42.59	30.84	-	24.29	-	46.66
Forward PE	60.30	35.20	53.58	35.07	-	-
PEG Ratio	3.36	2.42	3.57	2.34	-	-
PS Ratio	22.81	13.95	12.25	9.55	5.77	10.72
PB Ratio	6.43	3.68	2.47	1.79	1.90	3.15
P/TBV Ratio	9.60	5.56	4.27	4.26	7.54	7.86
P/FCF Ratio	50.89	76.44	21.50	27.22	9.44	36.98
P/OCF Ratio	50.70	75.74	21.10	25.29	8.21	32.87
EV/Sales Ratio	21.62	12.89	10.76	8.30	5.14	10.65
EV/EBITDA Ratio	44.13	46.23	142.34	23.51	18.48	16.61
EV/EBIT Ratio	58.61	84.30	-	110.96	331.97	24.78
EV/FCF Ratio	48.23	70.68	18.88	23.66	8.41	36.74
Debt / Equity Ratio	0.45	0.44	0.01	0.01	0.02	0.39
Debt / EBITDA Ratio	3.54	6.04	0.56	0.13	1.61	2.09
Debt / FCF Ratio	3.67	9.23	0.07	0.13	0.73	4.63
Net Debt / Equity Ratio	-0.33	-0.28	-0.30	-0.23	-0.21	-0.02
Net Debt / EBITDA Ratio	-2.56	-3.77	-19.72	-3.54	-2.27	-0.11
Net Debt / FCF Ratio	-2.66	-5.77	-2.62	-3.56	-1.03	-0.24
Asset Turnover	0.18	0.21	0.19	0.17	0.19	0.18
Inventory Turnover	1.16	1.25	0.58	0.56	2.60	2.31
Quick Ratio	20.48	21.18	7.94	12.11	2.45	10.24
Current Ratio	21.28	22.23	8.93	14.15	2.67	11.15
Return on Equity (ROE)	23.21%	13.47%	-0.53%	8.29%	-0.74%	9.98%
Return on Assets (ROA)	7.06%	3.95%	-4.89%	1.45%	0.63%	7.20%
Return on Invested Capital (ROIC)	15.55%	7.51%	-7.56%	2.22%	1.02%	12.29%
Return on Capital Employed (ROCE)	6.28%	3.38%	-2.70%	1.37%	0.32%	8.25%
Earnings Yield	2.45%	3.24%	-	4.12%	-	2.14%
FCF Yield	1.97%	1.31%	4.65%	3.67%	10.59%	2.70%
Buyback Yield / Dilution	-9.71%	-10.96%	-3.00%	-5.27%	2.19%	-2.50%
Total Shareholder Return	-9.71%	-10.96%	-3.00%	-5.27%	2.19%	-2.50%

SEC Filings: 10-K · 10-Q